GE Medical Systems is collaborating with a half-dozen healthcare and cancer resource agencies to roll out a Web site for women who want information about breast care and cancer.The site, www.herSource.com, was unveiled at a press conference in February
GE Medical Systems is collaborating with a half-dozen healthcare and cancer resource agencies to roll out a Web site for women who want information about breast care and cancer.
The site, www.herSource.com, was unveiled at a press conference in February along with the Senographe 2000D, GEs full-field digital mammography unit that has since gained FDA clearance (SCAN 3/15/00). Digital mammography and the Senographe 2000D are featured in the sites treatment section, along with MR, ultrasound, and PET information.
Diagnostic and treatment information on the site will extend beyond radiology in the future, said Janet Lippincott, manager of www.herSource.com.
We are trying to make sure people are aware of all different types of procedures, she said.
Users can also find breast cancer statistics, definitions associated with the disease, a list of FDA-approved breast imaging centers, and financial information. Clinical information on the site is provided by the National Cancer Institute, the FDA, and other sources.
A disclaimer reads that GE cannot provide site users with medical advice, but patients can use www.herSource.com to link up with an interactive consultant on a Web site run by the U.S. Department of Defense, which has a medical research component. The Department of Defense funded development of the link, titled the Breast Cancer Decision Guide, where women with pathology and biopsy reports can obtain more information about the results.
The Web site is paid for by GE Medical Systems, which envisions it as a nonprofit venture. In addition, GE has plans to construct more Web sites that explore other healthcare issues in the future, said Tesha Urban, GE spokesperson.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.